Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Applied Health Economics and Health Policy

Topics

Biology

Epidemiology

Economics

Medicine

Public Health

Show all topics

DOI

10.1007/s40258-024-00924-x